SSTR2 and neoplasm: In this context, new grading systems for EOR incorporating postoperative PET/CT or PET/MRI findings have already been proposed, but prospective validation is still lacking, and prognostic relevance of postoperative SSTR2 PET/CT for tumor recurrence ultimately remains unclear [30].